• About
  • Subscribe
  • Advertise
  • Contact
Thursday, December 5, 2024
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Ophthalmic insights Indigenous eye health

Questions over funding as IRIS performs 500th cataract surgery

by Myles Hume
November 25, 2020
in Indigenous eye health, Local, News
Reading Time: 4 mins read
A A
The IRIS team preparing for its 500th surgery with Rosemary in Katherine on 24 November. Image: IRIS Program

The IRIS team preparing for its 500th surgery with Rosemary in Katherine on 24 November. Image: IRIS Program

Share on FacebookShare on Twitter

The Indigenous and Remote Eye Health Service (IRIS) has this week delivered on its two-year government contract to perform 500 cataract surgeries, as the organisation warns of the disastrous implications if the program loses funding.

A specialist IRIS team travelled to Katherine, in the Northern Territory, earlier this week to conduct the final round of cataracts as part of the IRIS 2.0 program that also services Indigenous communities in Western Australia, New South Wales and Queensland.

Vanguard Health, operated by CEO Mr Tim Gallagher, was awarded a $2.2 million Federal Government grant in August 2018 to deliver the 500 cataract surgeries in priority areas by 30 June 2020.

Bill Glasson.

The deadline was extended to 31 December 2020 due to COVID-19, with the organisation expected to slightly overdeliver on its contractual agreement with more than a month to spare.

“I’m very proud of what IRIS has achieved, and proud of the professions of optometry and ophthalmology that have made a big difference to people’s lives,” Dr Bill Glasson, the IRIS co-chair and Queensland lead, told Insight.

“What I love about the program is, with the dollars we get, 99% of it goes into treating patients in their communities – no one’s being paid to sit in committee meetings, and those people who do sit on committees and advise do it for nothing because we think it’s such a great service.”

The origins of the IRIS program can be traced back to 2009 when the Rudd Labour government and then Health Minister Ms Nicola Roxon reached a settlement with Australian Society of Ophthalmologists (ASO) over its ‘Grandma’s not happy’ campaign.

The ASO successfully called for a reversal of the Federal Government’s decision to halve the Medicare rebate for cataract surgery. As part of the settlement, Roxon asked ophthalmologists to help fix the disastrously low cataract services in Indigenous and remote Australian communities. The ASO decided that money saved by the cataract rebate cut would go towards Indigenous cataract surgery and paediatric eye services.

This led to the IRIS 1.0 program, which performed thousands of eye health services and surgeries until 2014 when the funding expired.

Rosemary and Sally were the 500th and 501st patients to have a cataract procedure performed by IRIS. Rosemary in particular has been blind for the last year and needs continuous support from family. She is looking forward to fishing again and seeing her one year old granddaughter who lives in Palumpa. Image: IRIS Program

According to the ASO, the Australian Institute of Health and Welfare Indigenous Eye Health Measures 2016 report showed how the gap between Indigenous and non-Indigenous eye health had increased following the end of IRIS 1.0.

Between 2012–13 and 2013–14 – during IRIS 1.0 – the median waiting time for elective cataract surgery for Indigenous Australians dropped from 140 days to 112 days. After IRIS 1.0 ended, this then rose to 142 days in 2014–15. Over the same period, the median waiting time for non-Indigenous Australians remained stable at around 84–88 days.

In 2017–18, Indigenous Australians waited a median of 132 days for cataract surgery, while non-Indigenous Australians waiting 84 days.

Funding conundrum 

With IRIS reinstated in 2018, Glasson, a past president of the Australian Medical Association, hoped the government would continue to recognise the importance of the program and renew the contract for 2021 and beyond.

“Funding finishes at the end of this year and if we don’t have any more then we can’t deliver the service. I keep saying to the government it’s costing you bugger all money for the outcomes that we are delivering, so please continue to fund it,” he said.

Shirley was another patient IRIS treated in Katherine this week. Image:IRIS Program

“If it loses its funding, the service will fall apart and all these patients who already have three times the rate of vision loss compared to non-Indigenous Australians could blow out to six times more – we will have more people losing vision, losing confidence in themselves and sustaining falls and becoming depressed.

“Visual loss from cataracts is very treatable and cataract surgery I believe is the most cost-effective procedure on the Medicare schedule, without a doubt, in terms of the independence and self-esteem that it restores to the patient.”

A unique service 

Glasson said the program’s strength was its agility to deliver services to people in their own rural and remote communities. It removes the need of trying to take patients to services which is often fraught with logistical issues and fear of the unknown, leading to disengagement and failure to turn up to their appointment.

IRIS also places emphasis on establishing structures, with the local health workers playing an instrumental role in organisation and logistics so that the visiting team of eyecare possessional can provide an efficient service and see more patients.

“We also focus on having the same team going to the same population, such that relationships are developed between the eye surgeons and the patients requiring the service. When the surgeon returns from his or her outreach clinic to their home practice the health worker in the community can call that surgeon at any time about any queries relating to the patients that have just been treated or need treatment in the future,” Glasson said.

“Relationships between the eye health workers and those that live within the communities form the basis of a functional system that is sustainable into the future.”

More reading

Optometry student spearheads efforts to attract Indigenous Australians into university education

Roadmap falls short of 2020 target

Gov report shows ‘substantial’ Indigenous eye health improvements

 

Tags: ASOAustralian Society of OphthalmologistsDr Bill Glassoneye healthFundingIndigenousIRISIRIS 1.0IRIS 2.0IRIS ProgramTim GallagherVanguard Health

Related Posts

A new WA clinic will give Aboriginal communities and others greater access to eyecare. Image: Sawoon/stock.adobe.com

New clinic will help address inequities in Aboriginal eyecare

by Staff Writer
December 5, 2024

A new eye clinic aims to make a significant impact in transforming eyecare for Aboriginal communities in Western Australia. A...

Or lack of it, depending on where you live, is the concern of the CPMC and others. Image: BJP7images/stock.adobe.com.

Health ministers warned that fast-track changes could bring ‘postcode’ health care

by Staff Writer
December 5, 2024

Australia’s state health ministers have been warned that the proposed fast-track registration of Specialist International Medical Graduates (SIMGs) risks exacerbating...

Alcon has confirmed its new Unity systems are now registered in Australia, and will be commercially available in 2025. Image: Konektus Photo/Shutterstock.com.

All-new Alcon Unity vitreoretinal and cataract systems approved in Australia

by Myles Hume
December 4, 2024

Alcon has revealed its “highly anticipated” Unity Vitreoretinal Cataract System and Unity Cataract System have been included on the Australian...

Join our newsletter

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited